An analysis of the tumor biology of women with HR-positive, HER2-negative early breast cancer uncovered specific genomic alterations enriched in younger women.
Medscape Medical News
An analysis of the tumor biology of women with HR-positive, HER2-negative early breast cancer uncovered specific genomic alterations enriched in younger women.
Medscape Medical News